Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
56
Publications avec texte intégral
Open Access
46 %
Mots clés
Autoimmune diseases
MG patients
Experimental mouse models
Ferrites
Centres germinatifs ectopiques
Etiology
Immunology and Microbiology Section
Transcriptome
Immunity
Fragile X syndromes
Gd T cells
Interferon type-I
Exercise
Age
Chronic inflammation
Antimir-150
Interféron de type I
Myasthénie grave
Thymic epithelial cells
Lamin A/C nuclei
Adaptive immunity
Experimental autoimmune myasthenia gravis
Innate immunity
Interferon
Germinal center
Experimental models
FMR1
COVID-19
Interleukin 23
Quality of life
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Cytokines
Acides nucléiques endogènes
Autoimmunity
Interferon IFN
Chemokines
Myasthenia Gravis MG
Maladie auto-immune
Th17 cells
Interferonopathy
Thymus
AChR antibodies
Endogenous nucleic acids
Acetylcholine receptor
BAFF
Disease susceptibility
Myasthenia gravis
PBMC
CXCL13-CXCR5
Inflammation
Chronicity
Genetic associations
MYB
Genetics
Il-23
Human myoblasts
Cellules th17
LMNA
Early-onset myasthenia gravis
Gender
Inflammatory cytokines
Mass cytometry CyTOF
Long-term follow-up
B cells
Cardiomyopathy
Chemokine
Conduction disease
Thymoma
Germinal centers
Auto-immunité
Acetylcholine receptor antibodies
DICER
CD31
CCL21
COX2
Max
Acetylcholine receptors
Interleukine-23
Neuromuscular junction
Immunotherapy
Glucocorticoids
Complete Freund's adjuvant
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Follicular hyperplasia
Experimental autoimmune myasthenia gravis EAMG
Immune response
Interferon-β
Ectopic germinal centers
Autoimmune disease
Heart failure
Interferon de type I
Myoblasts
Clinical cell transplantation
Interferon type I
Immune regulation
Anticorps monoclonal
Animal models
M3243AG
CTCF
Macrophages